Last reviewed · How we verify
NCT07176819
Effectiveness of Gait Retraining in Female Runners With Patellofemoral Pain
NA trial testing Gait retraining in Patellofemoral Pain, PFP in 44 participants. Completed in 23 December 2023.
23 December 2023
Quick facts
| Lead sponsor | Beijing Sport University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 44 |
| Start date | 21 February 2023 |
| Primary completion | 23 December 2023 |
| Estimated completion | 23 December 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Gait retraining
- Education
Conditions studied
- Patellofemoral Pain, PFP — all drugs for Patellofemoral Pain, PFP →
Sponsor
Beijing Sport University
Who can join
Adults 18 to 45, female only, with Patellofemoral Pain, PFP. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patellofemoral pain (PFP) is the most common running-related overuse injury, with prevalence up to 17% among runners. Increased patellofemoral joint stress (PFJS) is a major biomechanical contributor to PFP. Traditional strengthening exercises improve function but do not alter running biomechanics. Gait retraining, particularly cadence modification, has been proposed as a promising approach to reduce PFJS and alleviate symptoms. However, evidence from randomized controlled trials remains limited. This study investigates whether wearable device-assisted gait retraining reduces pain, improves function, and modifies running biomechanics in female runners with PFP compared to education alone.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07176819
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Gait retraining
Trials testing the same drug.
- NCT03921801 — Effects of Improved Calf Muscle Function on Gait, Balance and Joint Loading in Older Adults · NA · completed
- NCT04221698 — Do Young Triathletes Have a Greater Predisposition to Suffer Running Injuries · NA · completed
Other recruiting trials for Patellofemoral Pain, PFP
Currently open trials in the same condition.
- NCT07384858 — Effects of Attentional Focus Strategies During Isokinetic Quadriceps Training on Strength and Functional Performance in · NA · recruiting
Other Beijing Sport University trials
Trials by the same sponsor.
- NCT07591194 — The Effects of Immersive Virtual Reality-Based Exergaming Combined With Transcranial Direct Current Stimulation on Execu · NA · not yet recruiting
- NCT07360821 — Investigation of Autonomic Stress Response Patterns in College Students With Varying Physical Activity Levels · not yet recruiting
- NCT07496944 — Effects of Blood Flow Restriction and Small-Sided Games on Soccer Passing and Dribbling Stability Under Fatigue · NA · completed
- NCT07509970 — Effects of Astaxanthin Supplementation on Soccer Performance Under Fatigue · NA · completed
- NCT07264907 — Tai Chi Improves Sleep Quality in Mild to Moderate Chronic Insomnia Patients · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07176819 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Sport University
- Last refreshed: 16 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07176819.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing